Nephrologists All Over India Prefer Cresp® as Their First Choice, Hb: Hemoglobin; rHuEPO: Recombinant human erythropoietin.

Cresp® is the first biosimilar of Darbepoetin Alfa!

A win–win for both medical practitioners and their patients

Convenience: Darbepoetin Alfa is administered weekly, fortnightly, or monthly as compared to rHuEPO’s three times a week.

Better patient compliance: Fewer administrations of Darbepoetin Alfa can improve patient compliance and enhance treatment outcomes.

Improved Hb control: Flexible dosing: Darbepoetin Alfa provides long-term control with minimal dose changes and a predictable rise in Hb level.

Improved Hb control: Darbepoetin Alfa provides long-term control with minimal dose changes and a predictable rise in Hb level.

Flexible dosing: Darbepoetin Alfa dose flexibility allows for weekly, fortnightly, or monthly administration with multiple strength options, effectively meeting a patient's dose titration needs.

Abbreviations ▼

Hb: Hemoglobin; rHuEPO: Recombinant human erythropoietin.

References ▼

Cresp. Available at: https://www.cresp.in/development.html. Accessed on: 19 August 2024.

LMRC Code: GGI-CO-A1-AQS-300021092-BANNERS-H24-0532

Disclaimer: For the use of a Registered Medical Practitioner, Hospital or Laboratory only.

The images are for illustrative representation only and do not depict actual medical products, procedures, or outcomes. Refer to official medical guidance and product information for accurate details.

All content including: text, images, audio, or other formats were created for medical educational purposes only. Offerings for continuing education are clearly identified and the appropriate target audience is identified. This communication is restricted for the use of HCPs and must not be shared in public domain. The opinions expressed in this video are solely the views of the speaker. The presentation may contain off label usage of drug(s) aimed at educational purpose only. Dr. Reddy’s Laboratories Ltd including but not limited its Affiliates strictly does not recommend any off label usage of its marketing products. Prior to treatment kindly refer to the latest prescribing information approved by the local authorities. No part of this content may be used, reproduced, transmitted or stored in any form without the written permission of Dr. Reddy’s.

Cresp 2

Cresp®(Biosimilar of darbepoetin alpha), a product by Dr. Reddy's is an erythropoiesis-stimulating agent which helps in treatment of renal anemia in pre-dialysis patients

Know more

Nephrologists All Over India Prefer Cresp® as Their First Choice!